Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
4.490
+0.110 (2.51%)
At close: Nov 22, 2024, 4:00 PM
4.400
-0.090 (-2.00%)
After-hours: Nov 22, 2024, 7:58 PM EST
Humacyte Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Humacyte stock have an average target of 12.71, with a low estimate of 4.00 and a high estimate of 25. The average target predicts an increase of 183.07% from the current stock price of 4.49.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Humacyte stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 4 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 7 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +167.26% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +167.26% | Nov 13, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +456.79% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $12 | Strong Buy | Maintains | $6 → $12 | +167.26% | Nov 5, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +456.79% | Oct 28, 2024 |
Financial Forecast
Revenue This Year
320.58K
Revenue Next Year
17.65M
from 320.58K
Increased by 5,405.72%
EPS This Year
-1.24
from -1.07
EPS Next Year
-0.86
from -1.24
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.6M | 42.1M | 308.0M | ||
| Avg | 320,576 | 17.7M | 130.8M | ||
| Low | n/a | 6.7M | 58.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 13,034.2% | 1,644.8% | ||
| Avg | - | 5,405.7% | 640.8% | ||
| Low | - | 1,978.8% | 233.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.04 | -0.70 | 1.25 | ||
| Avg | -1.24 | -0.86 | -0.18 | ||
| Low | -1.26 | -1.06 | -0.57 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.